美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

YARROW BIOSCIENCE, INC.

36.43

-1.7750-4.65%

盤後：36.430.00000.00%19:30 EDT

成交量：2.60萬

成交額：94.40萬

市值：9,724.75萬

市盈率：-1.67

高：38.38

開：37.00

低：35.50

收：38.20

52周最高：46.95

52周最低：14.03

股本：266.98萬

流通股本：61.15萬

量比：1.38

換手率：4.25%

股息：- -

股息率：- -

每股收益(TTM):-21.8600

每股收益(LYR):-66.8179

淨資產收益率：--

總資產收益率：--

市淨率：-1.37

市盈率(LYR):-0.55

資料載入中...

總覽公司新聞資訊公告

Yarrow Bioscience完成與VYNE合併，Graves病藥物YB-101啓動II期臨床

环球市场播报

Vyne Therapeutics 更新現金派息、反向拆股及與 Yarrow Bioscience 擬議合併交割預期時間安排

VYNE Therapeutics宣佈1比50反向拆股並就與Yarrow Bioscience擬議合併相關的特別股息提供最新信息

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/YARW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YARW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YARW\",,,,,undefined,":{"symbol":"YARW","market":"US","secType":"STK","nameCN":"YARROW BIOSCIENCE, INC.","latestPrice":36.425,"timestamp":1787342400000,"preClose":38.2,"halted":0,"volume":25981,"hourTrading":{"tag":"盘后","latestPrice":36.425,"preClose":36.425,"latestTime":"19:30 EDT","volume":10,"amount":369.5,"timestamp":1787355005444,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04646596858638758,"floatShares":611500,"shares":2669800,"eps":-21.86,"marketStatus":"休市中","change":-1.775,"latestTime":"08-21 16:00:00 EDT","open":37,"high":38.38,"low":35.5,"amount":943966.2960069999,"amplitude":0.075393,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-21.86,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":38.2,"postHourTrading":{"tag":"盘后","latestPrice":36.425,"preClose":36.425,"latestTime":"19:30 EDT","volume":10,"amount":369.5,"timestamp":1787355005444,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3824092677883641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YARW\",,,,,undefined,":{"symbol":"YARW","floatShares":611500,"roa":"--","roe":"--","lyrEps":-66.817882,"volumeRatio":1.3824092677883641,"shares":2669800,"dividePrice":0,"high":38.38,"amplitude":0.075393,"preClose":38.2,"low":35.5,"week52Low":14.025,"pbRate":"-1.37","week52High":46.95,"institutionHeld":0,"latestPrice":36.425,"eps":-21.86,"divideRate":0,"volume":25981,"delay":0,"ttmEps":-21.86,"open":37,"prevYearClose":29.005,"prevWeekClose":42.49,"prevMonthClose":35.02,"prevQuarterClose":32.535,"fiveDayClose":42.49,"twentyDayClose":25.45,"sixtyDayClose":33.995},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YARW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"YARW","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.14},{"market":"US","date":"2026-07-27","symbol":"YARW","defaultRemindTime":1785159000000,"type":"split","dateTimestamp":1785124800000,"forFactor":50,"toFactor":1,"ratio":50},{"date":"2026-07-24","symbol":"YARW","amount":0.40242,"announcedDate":"2026-07-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-22","defaultRemindTime":1784899800000,"name":"VYNE Therapeutics Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-23","payableDate":"2026-07-22","currency":"USD","dateTimestamp":1784865600000,"payDate":"2026-07-23"},{"market":"US","date":"2026-05-15","symbol":"YARW","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.08},{"date":"2026-02-27","symbol":"YARW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772182800000,"name":null,"time":"盤前","dateTimestamp":1772168400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YARW\",market:\"US\",,,undefined,":[{"executeDate":"2026-07-24","recordDate":"2026-07-22","paymentDate":"2026-07-23","value":0.40242,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YARW\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1786680000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/YARW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"YARW","date":"2026-08-21","current":-1.666285,"percent":1,"low":-0.423388,"twenty":-0.421318,"median":-0.411606,"eighty":-0.406626,"high":-0.376652,"avg":-0.410215,"sd":0.013222,"marketCap":106960000},"quantilePoints":[{"date":"2026-08-14","current":-0.421219,"twenty":-0.422047,"median":-0.421219,"eighty":-0.412759,"marketCap":119616000},{"date":"2026-08-21","current":-0.376652,"twenty":-0.421318,"median":-0.411606,"eighty":-0.406626,"marketCap":106960000}],"updateTime":1787482792523},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"YARW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654045362","title":"Yarrow Bioscience完成與VYNE合併，Graves病藥物YB-101啓動II期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045362","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654045362?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 21:56","pubTimestamp":1785160560,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Yarrow Bioscience今日宣布，已完成与VYNE Therapeutics的合并，并同步完成约2亿美元私募融资。合并后公司将继续以Yarrow Bioscience名义运营，其普通股预计于7月28日在纳斯达克资本市场挂牌交易，股票代码为“YARW”。目前，YB-101已启动针对GD患者的IIa/IIb期临床试验，并获得美国FDA快速通道认定，IIa期数据预计于2027年下半年读出。Yarrow计划在获得IIa期数据后，于2028年上半年启动约200例患者的IIb剂量探索阶段。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-27/doc-inikhiss8341457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["YARW","BK4173","BK4007","YB","VYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150755970","title":"Vyne Therapeutics 更新現金派息、反向拆股及與 Yarrow Bioscience 擬議合併交割預期時間安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1150755970","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150755970?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 04:36","pubTimestamp":1784838975,"startTime":"0","endTime":"0","summary":"Vyne Therapeutics 发布了最新公告。该公告涉及现金分红、反向拆股，以及其与 Yarrow Bioscience 拟议合并的预期交割时间。这一系列关键事项的最新进展，现已向市场公开。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YARW","BK4007","VYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118603468","title":"VYNE Therapeutics宣佈1比50反向拆股 並就與Yarrow Bioscience擬議合併相關的特別股息提供最新信息","url":"https://stock-news.laohu8.com/highlight/detail?id=1118603468","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118603468?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 20:01","pubTimestamp":1784635272,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics Inc. 宣布，公司将实施1比50的反向股票拆分，并提供了与拟议中的Yarrow Bioscience合并案相关的特别股息的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","YARW","VYNE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}